Back to mobile site

Clementia Pharmaceuticals Inc. (CMTA) PT Raised to $28 at Leerink Partners

October 24, 2018 8:31 AM EDT
Get Alerts CMTA Hot Sheet
Price: $26.35 --0%

Rating Summary:
    3 Buy, 3 Hold, 0 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE

Leerink Partners analyst Joseph Schwartz raised the price target on Clementia Pharmaceuticals Inc. (NASDAQ: CMTA) to $28.00 (from $23.00) while maintaining a Outperform rating.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Analyst PT Change